Back to results
US 2017/0247667 A1Published application
Novel p450-bm3 variants with improved activity
AssigneeCodexis, Inc.
InventorsRobert Osborne, Vesna Mitchell, Khin Yu Naing Htwe, Xiyun Zhang, Erika M. Milczek, Jeffrey C. Moore
Life of this patent
Estimating the term…
Abstract
The present invention provides improved P450-BM3 variants with improved activity. In some embodiments, the P450-BM3 variants exhibit improved activity over a wide range of substrates.
Claims13
A recombinant cytochrome P450-BM3 variant having at least 90% sequence identity to a polypeptide sequence comprising the sequence set forth in SEQ ID NOS:2, 4, 6, 8, 12, 14, or 16.
Dependencies are inferred from the claim text.